Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ARMSTRONG A. R., PEART H. E. A comparison between the behavior of Eskimos and non-Eskimos to the administration of isoniazid. Am Rev Respir Dis. 1960 Apr;81:588–594. doi: 10.1164/arrd.1960.81.4.588. [DOI] [PubMed] [Google Scholar]
- BARCLAY W. R., EBERT R. H., LE ROY G. V., MANTHEI R. W., ROTH L. J. Distribution and excretion of radioactive isoniazid in tuberculous patients. J Am Med Assoc. 1953 Apr 18;151(16):1384–1388. [PubMed] [Google Scholar]
- BELL J. C., RIEMENSNIDER D. K., MITCHELL R. S. Effect of certain aromatic amines on serum isoniazid concentrations in tuberculous patients. Am Rev Tuberc. 1957 Jul;76(1):152–158. doi: 10.1164/artpd.1957.76.1.152. [DOI] [PubMed] [Google Scholar]
- BERTE S. J., LEIFHEIT H. C., DEWLETT H. J., TUCKER E. B. A critical analysis of the accuracy of a chemical and biologic method of determining serum free isoniazid. Am Rev Tuberc. 1959 Mar;79(3):344–350. doi: 10.1164/artpd.1959.79.3.344. [DOI] [PubMed] [Google Scholar]
- BONICKE R., REIF W. Enzymatische Inaktivierung von Isonicotinsäurehydrazid im menschlichen und tierischen Organismus. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1953;220(4):321–323. [PubMed] [Google Scholar]
- DORMER B. A., HARRISON I., SWART J. A., VIDOR S. R. Prophylactic isoniazid: protection of infants in a tuberculosis hospital. Lancet. 1959 Nov 21;2(7108):902–903. doi: 10.1016/s0140-6736(59)90820-7. [DOI] [PubMed] [Google Scholar]
- DRABKIN D. L. Imperfection: biochemical phobias and metabolic ambivalence. Perspect Biol Med. 1959;2(4):473–517. doi: 10.1353/pbm.1959.0037. [DOI] [PubMed] [Google Scholar]
- ELMENDORF D. F., Jr, CAWTHON W. U., MUSCHENHEIM C., McDERMOTT W. The absorption, distribution, excretion, and short-term toxicity of isonicotinic acid hydrazide (nydrazid) in man. Am Rev Tuberc. 1952 Apr;65(4):429–442. doi: 10.1164/art.1952.65.4.429. [DOI] [PubMed] [Google Scholar]
- GRUNBERG E., LEIWANT B., D'ASCENSIO I. L., SCHNITZER R. J. On the lasting protective effect of hydrazine derivatives of isonicotinic acid in the experimental tuberculosis infection of mice. Dis Chest. 1952 Apr;21(4):369–377. doi: 10.1378/chest.21.4.369. [DOI] [PubMed] [Google Scholar]
- HARRIS H. W., KNIGHT R. A., SELIN M. J. Comparison of isoniazid concentrations in the blood of people of Japanese and European descent; therapeutic and genetic implications. Am Rev Tuberc. 1958 Dec;78(6):944–948. doi: 10.1164/artpd.1958.78.6.944. [DOI] [PubMed] [Google Scholar]
- HUGHES H. B., BIEHL J. P., JONES A. P., SCHMIDT L. H. Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis. Am Rev Tuberc. 1954 Aug;70(2):266–273. doi: 10.1164/art.1954.70.2.266. [DOI] [PubMed] [Google Scholar]
- HUGHES H. B. On the metabolic fate of isoniazid. J Pharmacol Exp Ther. 1953 Dec;109(4):444–452. [PubMed] [Google Scholar]
- MAHER J. R., WHITNEY J. M., CHAMBERS J. S., STANONIS D. J. The quantitative determination of isoniazid and para-aminosalicylic acid in body fluids. Am Rev Tuberc. 1957 Nov;76(5):852–861. doi: 10.1164/artpd.1957.76.5.852. [DOI] [PubMed] [Google Scholar]
- ROBITZEK E. H., SELIKOFF I. J., ORNSTEIN G. G. Chemotherapy of human tuberculosis with hydrazine derivatives of isonicotinic acid; preliminary report of representative cases. Q Bull Sea View Hosp. 1952 Jan;13(1):27–51. [PubMed] [Google Scholar]
- SELIKOFF I. J., ROBITZEK E. H. Tuberculosis chemotherapy with hydrazine derivatives of isonicotinic acid. Dis Chest. 1952 Apr;21(4):385–438. doi: 10.1378/chest.21.4.385. [DOI] [PubMed] [Google Scholar]
- Stern C. THE HARDY-WEINBERG LAW. Science. 1943 Feb 5;97(2510):137–138. doi: 10.1126/science.97.2510.137. [DOI] [PubMed] [Google Scholar]